Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.450
-0.050 (-3.33%)
At close: Sep 17, 2025, 4:00 PM EDT
1.450
0.00 (0.00%)
After-hours: Sep 17, 2025, 4:25 PM EDT
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $234.82 million as of September 17, 2025. Its market cap has decreased by -86.91% in one year.
Market Cap
234.82M
Enterprise Value
48.53M
1-Year Change
-86.91%
Ranking
Category
Stock Price
$1.45
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $234.82M, a decrease of -90.91%. That is a compound annual growth rate of -69.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 242.92M | -85.82% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |